The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
Abstract
BACKGROUND: Intravenous tissue plasminogen activator (tPA) is the only approved therapy for acute ischemic stroke, although only 2% of patients with stroke receive intravenous tPA nationally. OBJECTIVE: To determine the rate of tPA use for stroke in the Cleveland, Ohio, community and the reasons why patients were excluded from thrombolysis treatment. DESIGN: Retrospective cohort study. SETTING: Community. Subjects Patients admitted because of stroke to the 9 Cleveland Clinic Health System hospitals from June 15, 1999, to June 15, 2000. MAIN OUTCOME MEASURES: Utilization of intravenous tPA and reasons for ineligibility. RESULTS: There were 1923 admissions for ischemic stroke in the 1-year period. Of these, 288 (15.0%) arrived within the 3-hour time window, and approximately 6.9% were considered eligible for tPA. The most common reasons for exclusion among patients arriving within 3 hours were mild neurologic impairment and rapidly improving symptoms. The overall rate of tPA use among patients presenting within 3 hours was 19.4%, and the rate of use among eligible patients was 43.4% (n = 56). The use of tPA did not differ significantly according to race or sex. CONCLUSIONS: Only 15% of patients arrived within the 3-hour time window for intravenous tPA, making delay in presentation the most common reason patients were ineligible for i.v. thrombolysis. Neurologic criteria were the second most common group of exclusions. Overall tPA use was low, but it was used in nearly half of all patients with no documented contraindications. Intravenous tPA use in a community setting can compare favorably with the rate of use seen in academic medical settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Why Don't Physicians Follow Clinical Practice Guidelines?: A Framework for Improvement
Cabana, M. D., Rand, C. S., Powe, N. R., Wu, A. W., Wilson, M. H., Abboud, P.-A. C., & Rubin, H. R. (1999) · JAMA · doi:10.1001/jama.282.15.1458 · Cited by 6,677
Adams, H. P., Brott, T. G., Furlan, A. J., Gomez, C. R., Grotta, J., Helgason, C. M., Kwiatkowski, T., Lyden, P. D., Marler, J. R., Torner, J., et al. (1996) · Circulation · doi:10.1161/01.cir.94.5.1167 · Cited by 730
Self-citationWhy are stroke patients excluded from TPA therapy?: An analysis of patient eligibility
Barber, P. A., Zhang, J., Demchuk, A. M., Hill, M. D., & Buchan, A. M. (2001) · Neurology · doi:10.1212/wnl.56.8.1015 · Cited by 704
Ellerbeck, E. F. (1995) · JAMA · doi:10.1001/jama.1995.03520430045037 · Cited by 374
Reed, S. D., Cramer, S. C., Blough, D. K., Meyer, K., & Jarvik, J. G. (2001) · Stroke · doi:10.1161/01.str.32.8.1832 · Cited by 255
Practice Advisory [RETIRED]: Thrombolytic therapy for acute ischemic stroke--Summary Statement
(1996) · Neurology · doi:10.1212/wnl.47.3.835 · Cited by 227
Johnston, S. C., Fung, L. H., Gillum, L. A., Smith, W. S., Brass, L. M., Lichtman, J. H., & Brown, A. N. (2001) · Stroke · doi:10.1161/01.str.32.5.1061 · Cited by 206
Tilley, B. C., Lyden, P. D., Brott, T. G., Lü, M., Levine, S. R., & Welch, K. M. A. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550240020008 · Cited by 136
Hayashi, Y., Kai, Y., Mohri, M., Uchiyama, N., & Hamada, J. (2008) · Acta neurochirurgica. Supplementum · doi:10.1007/978-3-211-75718-5_65 · Cited by 5
Cited by
Nogueira, R. G., Lutsep, H. L., Gupta, R., Jovin, T. G., Albers, G. W., Walker, G. A., Liebeskind, D. S., & Smith, W. S. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61299-9 · Cited by 1,110
Demaerschalk, B. M., Kleindorfer, D. O., Adeoye, O. M., Demchuk, A. M., Fugate, J. E., Grotta, J. C., Khalessi, A. A., Levy, E. I., Palesch, Y. Y., Prabhakaran, S., et al. (2016) · Stroke · doi:10.1161/str.0000000000000086 · Cited by 670
Streamlining of prehospital stroke management: the golden hour
Fassbender, K., Balucani, C., Walter, S., Levine, S. R., Haass, A., & Grotta, J. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70100-5 · Cited by 317
Schwamm, L. H., Ali, S. F., Reeves, M. J., Smith, E. E., Saver, J. L., Messe, S., Bhatt, D. L., Grau-Sepulveda, M. V., Peterson, E. D., & Fonarow, G. C. (2013) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.111.000095 · Cited by 305
Zhang, K., Tu, M., Gao, W., Cai, X., Song, F., Chen, Z., Zhang, Q., Wang, J., Jin, C., Shi, J., et al. (2019) · Nano Letters · doi:10.1021/acs.nanolett.8b04729 · Cited by 299
Metadata
- Authors
- Katzan, I. L., Hammer, M. D., Hixson, E. D., Furlan, A. J., Abou-Chebl, A., & Nadzam, D. M.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2004-03-01
- Volume
- 61
- Issue
- 3
- Pages
- 346
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W2018156750
- Cited by
- 289
- References
- 9
- FWCI
- 13.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke. https://app.cochat.ai/papers/10.1001/archneur.61.3.346
- The paper
- Katzan, I. L., Hammer, M. D., Hixson, E. D., Furlan, A. J., Abou-Chebl, A., & Nadzam, D. M. (2004). Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke. Archives of Neurology. https://doi.org/10.1001/archneur.61.3.346
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
